Home » Topics » BioWorld Science

BioWorld Science
RSS

Aronex reports clinical progress of Annamycin

May 21, 1997

Pranlukast evaluated in numerous preclinical and clinical studies

May 21, 1997

Ibex Technologies presents data on heparin neutralization agent

May 21, 1997

Merck updates development of higher dose Zocor

May 21, 1997

Preliminary results indicate potential for AML treatment

May 21, 1997

Preliminary phase I/II results for Vertex's VX-710

May 21, 1997

NIH funds Cognetix's research on antiseizure drug

May 21, 1997

Techniclone reports promising results from brain cancer treatment study

May 21, 1997

Rhone-Poulenc Rorer launches Zagam in the U.S.

May 21, 1997

Company Profile: MitoKor

May 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
Anle-138b reduces mHTT aggregation, improves pathological phenotypes in Huntington’s models
BioWorld Science
Anle-138b (emrusolmin) is a diphenylpyrazole compound that directly interacts with oligomeric species of disease-related aggregating proteins, reducing aggregate...